Document is current

Article History

Accepted: 29 October 2024

First Online: 18 November 2024

Declarations

:

: The authors are supported by The Department of Defense (BGB, OC170228, OC200302, OC200225), The American Cancer Society (BGB, RSG-19-129-01-DDC), The Ovarian Cancer Research Alliance (BGB), and the National Institutes of Health (BGB, National Cancer Institute R37CA261987 and R01CA285446; ND, R00HG012945)

: Shijuan Lin, Lily L. Nguyen, Alexandra McMellen, Michael S. Leibowitz, Natalie Davidson, Daniel Spinosa, and Benjamin G. Bitler have no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: SL completed the literature review, wrote the manuscript, and revised the manuscript. LLN completed the literature review and reviewed the manuscript. AMcM provided critical insight on ovarian cancer dissemination and edited the manuscript. MSL provided critical insight on clinical decision making and edited the manuscript. ND provided critical insight on machine learning approaches, and wrote and edited the manuscript. DS provided critical gynecologic oncology insight, and wrote and edited the manuscript. BGB oversaw the development of the manuscript, and wrote, edited, and revised the manuscript.